Metformin protects against apoptosis and senescence in nucleus pulposus cells and ameliorates disc degeneration in vivo.

Chen D, Xia D, Pan Z, Xu D, Zhou Y, Wu Y, Cai N, Tang Q, Wang C, Yan M, Zhang JJ, Zhou K, Wang Q, Feng Y, Wang X, Xu H, Zhang X, Tian N. · 2016

Read Metformin protects against apoptosis and senescence in nucleus pulposus cells and ameliorates disc degeneration in vivo. by Chen D, Xia D, Pan Z, Xu D, Zhou Y, Wu Y, Cai N, Tang Q, Wang C, Yan M, Zhang JJ, Zhou K, Wang Q, Feng Y, Wang X, Xu H, Zhang X, Tian N. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5133996.txt.

Introduction

Deheng Chen and a large team of co-authors tested metformin against disc degeneration in Cell Death and Disease in 2016. The diabetes drug is known to switch on autophagy, the cell's recycling system, and worn spinal discs suffer from cell death and aging in their soft centers.

In lab tests, metformin shielded disc center cells from a chemical stress that normally drives death and aging, and it switched on recycling in step with dose and time. Blocking recycling partly removed the protection, showing the mechanism at work. The drug also favored building genes over breaking genes in the cells. In rats with puncture-damaged discs, metformin treatment eased degeneration, which the authors offer as a candidate therapy for a condition with no effective drugs.

Catalog record

CREATORChen D, Xia D, Pan Z, Xu D, Zhou Y, Wu Y, Cai N, Tang Q, Wang C, Yan M, Zhang JJ, Zhou K, Wang Q, Feng Y, Wang X, Xu H, Zhang X, Tian N.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5133996

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Metformin protects against apoptosis and senescence in nucleus pulposus cells and ameliorates disc degeneration in vivo By Deheng Chen, Dongdong Xia, Zongyou Pan, Daoliang Xu, Yifei Zhou, Yaosen Wu, Ningyu Cai, Qian Tang, Chenggui Wang, Meijun Yan, Jing Jie Zhang, Kailiang Zhou Published in: Cell Death & Disease DOI: 10.1038/cddis.2016.334 ABSTRACT Intervertebral disc degeneration (IDD) is a complicated process that involves both cellular apoptosis and senescence. Metformin has been reported to stimulate autophagy, whereas autophagy is shown to protect against apoptosis and senescence. Therefore, we hypothesize that metformin may have therapeutic effect on IDD through autophagy stimulation. The effect of metformin on IDD was investigated both in vitro and in vivo. Our study showed that metformin attenuated cellular apoptosis and senescence induced by tert-butyl hydroperoxide in nucleus pulposus cells. Autophagy, as well as its upstream regulator AMPK, was activated by metformin in nucleus pulposus cells in a dose- and time-dependent manner. Inhibition of autophagy by 3-MA partially abolished the protective effect of metformin against nucleus pulposus cells' apoptosis and senescence, indicating that autophagy was involved in the protective effect of metformin on IDD. In addition, metformin was shown to promote the expression of anabolic genes such as Col2a1 and Acan expression while inhibiting the expression of catabolic genes such as Mmp3 and Adamts5 in nucleus pulposus cells. In vivo study illustrated that metformin treatment could ameliorate IDD in a puncture-induced rat model. Thus, our study showed that metformin could protect nucleus pulposus cells against apoptosis and senescence via autophagy stimulation and ameliorate disc degeneration in vivo, revealing its potential to be a therapeutic agent for IDD. Lower back pain is one of the most common musculoskeletal disorders that lead to low quality of life and high economic cost for the society. By 2013, up to 80% of the people suffered from low back pain in different stages of their lives.1 Intervertebral disc degeneration (IDD) has been reported to be the major cause for low back pain.2, 3 However, until recently there are no efficacious drugs for IDD therapy. The intervertebral disc is composed of a gelatinous inner core, the nucleus pulposus, and tough outer rings, the annulus fibrosus. The gelatinous nucleus pulposus is the main functional composition of discs, which help them to confront diverse mechanical impact, whereas the tough annulus fibrosus is thought to form a circular ring structure to support the nucleus pulposus. Nucleus pulposus is of vital importance to physiological function maintenance of discs. Nucleus pulposus cells are the main type of cells resident in nucleus pulposus; they produce extracellular matrix (ECM) such as collagen I, collagen II and proteoglycan, which are the main components of the gelatinous tissues of nucleus pulposus.4 Excessive apoptosis and senescence of nucleus pulposus cells are proven to play a significant role in the process of IDD, and have been proposed to be the therapeutic target for IDD.5, 6, 7, 8 Autophagy is a catabolic process through which cells degrade dysfunctional organelles and proteins to protect against cellular stresses.9 Autophagy is closely associated with apoptosis and senescence in the pathological process of many degenerative diseases, including osteoarthritis,10 age-related macular degeneration11 and Alzheimer's disease.12 Studies from our group and other groups showed that autophagy is a protective mechanism that nucleus pulposus cells used to confront apoptosis and senescence, and activation of autophagy could alleviate IDD.13, 14, 15 Metformin is one of the most widely used hypoglycemic drugs for the treatment of type 2 diabetes. It has been demonstrated recently that metformin could stimulate autophagy in various tissues including in brain,16, 17 kidney18 and heart,19 but not yet in nucleus pulposus. We hypothesize that metformin may have protective effects on IDD via autophagy stimulation. Therefore, we applied tert-butyl hydroperoxide (TBHP) to induce oxidative stress, which is a common pathological mechanism of both apoptosis and senescence20 in the nucleus pulposus cells in this study. We investigated the effects of metformin on apoptosis and senescence in nucleus pulposus cells under oxidative stress and also detected anabolic and catabolic gene expression in nucleus pulposus cells under metformin treatment. In the end, we evaluated the therapeutic potential of metformin in a puncture-induced rat IDD model. RESULTS Metformin treatment decreases apoptosis and senescence in nucleus pulposus cells As shown in Figure 1a, metformin was not cytotoxic to nucleus pulposus cells after 24 h at concentrations of ⩽200 μM. However, the cell viability was decreased under TBHP treatment in a dose-dependent manner. Metformin showed significant protective effect against the TBHP-induced cell death (Figures 1b and c). Nucleus pulposus cells shrunk in size, there was more vacuole formation and they floated finally in the medium under TBHP, whereas metformin could protect cells against apoptosis induced by TBHP (Figure 1d). The western blotting results also showed that TBHP (100 μM) markedly increased the expression of apoptosis-related protein (cleaved-caspase3) (P<0.01) and classical senescence marker (p16INK4a) (P<0.01), whereas pretreatment with metformin inhibited the TBHP-induced increase in protein content of cleaved-caspase3 and p16INK4a in a dose-dependent manner (Figures 1e–g) (P<0.01). The real-time PCR results also showed that TBHP treatment reduced mRNA levels of the major ECM synthesis gene Col2a1, whereas metformin could attenuate the loss of Col2a1 expression (Figure 1h) (P<0.01). Metformin activates AMPK and induces autophagy in the nucleus pulposus cells The LC3-II/LC3-I ratio, Beclin-1 and SQSTM1/P62, which were regarded as indicators of autophagy formation, as well as the ratio of p-AMPK/AMPK, were detected by western blotting. As shown in Figures 2a–d, the ratio of the p-AMPK/AMPK and LC3-II/LC3-I, as well as the expression of Beclin-1 in nucleus pulposus cells, was increased 24 h after metformin treatment in a dose-dependent ratio; however, the level of p62 was decreased under metformin treatment in a dose-dependent manner. We subsequently determined the p-AMPK/AMPK ratio, LC3-II/LC3-I ratio, Beclin-1 and P62 at different times after metformin treatment (100 μM). The ratio of p-AMPK/AMPK was significantly increased from the time point of 6 h, peaked at 24 h (P<0.01) and started to decrease from 48 h. Accordingly, the increment of the LC3-II/LC3-I ratio was observed to emerge from 6 h and reach a peak within 24 h (P<0.01), whereas SQSTM1/P62 significantly degraded with time, suggesting a consistently increased AMPK-dependent autophagy flux (Figures 2e–h) (P<0.01). We also detected the expression of autophagy-related protein, such as ATG3, ATG7 and ATG12-ATG5. As expected, the expression of these ATGs in nucleus pulposus cells was increased 24 h after metformin treatment in a dose-dependent ratio (Supplementary Figure S1). Autophagosomes and autophagolysosomes were observed by transmission electron microscopy, which is a standard method to check autophagy activation. Compared with the cells treated with Dulbecco's modified Eagle's medium (DMEM), the metformin-treated cells (100 μM) exhibited more autophagosomes and autophagolysosomes in the cytoplasm (Figure 2i). Inhibition of AMPK by siRNA significantly attenuated metformin-induced autophagy in nucleus pulposus cells To further investigate the role of AMPK in metformin-induced autophagy in nucleus pulposus cells, cells were transfected with AMPK-siRNA before they received metformin. The inhibitory effect of small interfering RNA (siRNA) on metformin-induced AMPK activation is shown in Figures 3a and b. Compared with the metformin group and the negative control siRNA group, the AMPK-siRNA group markedly reduced the ratio of LC3-II/LC3-I and beclin-1 level after metformin treatment (Figure 3c, P<0.01), and this result was further confirmed by immunofluorescence analysis

Read the complete text